バイオマーカー市場は、個別化医療に対する需要の高まりと慢性疾患の発生率の高さにより、予測期間中に2,496億ドルに達すると予測されます。バイオマーカー市場の成長は、製薬およびバイオテクノロジー研究への多額の資金提供と、医療費の増加によってさらに推進されています。さらに、ゲノミクス、プロテオミクス、メタボロミクスの各分野で新しいバイオマーカーが発見されたことによって、市場は拡大しています。これらのバイオマーカーは、安全性、有効性、予測バイオマーカーなどのさまざまな基準に基づいて分類されます。それらは、脳障害、癌、心臓病などのさまざまな医療領域で使用されています。しかし、その成長性にもかかわらず、高い開発コストや厳しい法規制などの課題が存在します。このように、バイオマーカー市場は、医薬品開発や臨床診断での使用により拡大すると予測されており、ヘルスケアソリューションを提供する上での重要性が高まっています。
目次
Table of Content
1. Executive Summary
1.1. Regional Market Share
1.2. Business Trends
1.3. Biomarkers Market: COVID-19 Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot
2. Research Methodology
2.1. Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation
3. Market Characteristics
3.1. Market Definition
3.2. Biomarkers Market: COVID-19 Impact
3.3. Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. Biomarkers Market - Industry Insights
4.1. Industry Segmentation
4.2. COVID-19 overview of world economy
4.3. Industry Ecosystem Channel Analysis
4.4. Innovation & Sustainability
5. Macroeconomic Indicators
6. Recent Developments
7. Market Dynamics
7.1. Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4. Market Restraints
7.5. Market Trends
8. Risk Analysis
9. Market Analysis
9.1. Porter's Five Forces
9.2. PEST Analysis
9.2.1. Political
9.2.2. Economic
9.2.3. Social
9.2.4. Technological
10. Biomarkers Market
10.1. Overview
10.2. Historical Analysis (2019-2022)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11. Biomarkers Market Size & Forecast 2024A-2034F
11.1. Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1. By Type
11.3.1.1. Safety
11.3.1.1.1. By Value (USD Million) 2024-2034F
11.3.1.1.2. Market Share (%) 2024-2034F
11.3.1.1.3. Y-o-Y Growth (%) 2024-2034F
11.3.1.2. Efficacy
11.3.1.2.1. By Value (USD Million) 2024-2034F
11.3.1.2.2. Market Share (%) 2024-2034F
11.3.1.2.3. Y-o-Y Growth (%) 2024-2034F
11.3.1.3. Validation
11.3.1.3.1. By Value (USD Million) 2024-2034F
11.3.1.3.2. Market Share (%) 2024-2034F
11.3.1.3.3. Y-o-Y Growth (%) 2024-2034F
11.3.2. By Application
11.3.2.1. Diagnostics Development
11.3.2.1.1. By Value (USD Million) 2024-2034F
11.3.2.1.2. Market Share (%) 2024-2034F
11.3.2.1.3. Y-o-Y Growth (%) 2024-2034F
11.3.2.2. Drug Discovery and Development
11.3.2.2.1. By Value (USD Million) 2024-2034F
11.3.2.2.2. Market Share (%) 2024-2034F
11.3.2.2.3. Y-o-Y Growth (%) 2024-2034F
11.3.2.3. Personalized Medicine
11.3.2.3.1. By Value (USD Million) 2024-2034F
11.3.2.3.2. Market Share (%) 2024-2034F
11.3.2.3.3. Y-o-Y Growth (%) 2024-2034F
11.3.2.4. Disease Risk Assessment
11.3.2.4.1. By Value (USD Million) 2024-2034F
11.3.2.4.2. Market Share (%) 2024-2034F
11.3.2.4.3. Y-o-Y Growth (%) 2024-2034F
11.3.2.5. Others
11.3.2.5.1. By Value (USD Million) 2024-2034F
11.3.2.5.2. Market Share (%) 2024-2034F
11.3.2.5.3. Y-o-Y Growth (%) 2024-2034F
11.3.3. By Product Type
11.3.3.1. Consumables
11.3.3.1.1. By Value (USD Million) 2024-2034F
11.3.3.1.2. Market Share (%) 2024-2034F
11.3.3.1.3. Y-o-Y Growth (%) 2024-2034F
11.3.3.2. Services
11.3.3.2.1. By Value (USD Million) 2024-2034F
11.3.3.2.2. Market Share (%) 2024-2034F
11.3.3.2.3. Y-o-Y Growth (%) 2024-2034F
11.3.3.3. Software
11.3.3.3.1. By Value (USD Million) 2024-2034F
11.3.3.3.2. Market Share (%) 2024-2034F
11.3.3.3.3. Y-o-Y Growth (%) 2024-2034F
11.3.4. By Technology
11.3.4.1. Safety Biomarkers
11.3.4.1.1. By Value (USD Million) 2024-2034F
11.3.4.1.2. Market Share (%) 2024-2034F
11.3.4.1.3. Y-o-Y Growth (%) 2024-2034F
11.3.4.2. Efficacy Biomarkers
11.3.4.2.1. By Value (USD Million) 2024-2034F
11.3.4.2.2. Market Share (%) 2024-2034F
11.3.4.2.3. Y-o-Y Growth (%) 2024-2034F
11.3.4.3. Validation Biomarkers
11.3.4.3.1. By Value (USD Million) 2024-2034F
11.3.4.3.2. Market Share (%) 2024-2034F
11.3.4.3.3. Y-o-Y Growth (%) 2024-2034F
11.3.5. By Indication
11.3.5.1. Cancer
11.3.5.1.1. By Value (USD Million) 2024-2034F
11.3.5.1.2. Market Share (%) 2024-2034F
11.3.5.1.3. Y-o-Y Growth (%) 2024-2034F
11.3.5.2. Cardiovascular Disorders
11.3.5.2.1. By Value (USD Million) 2024-2034F
11.3.5.2.2. Market Share (%) 2024-2034F
11.3.5.2.3. Y-o-Y Growth (%) 2024-2034F
11.3.5.3. Neurological Disorders
11.3.5.3.1. By Value (USD Million) 2024-2034F
11.3.5.3.2. Market Share (%) 2024-2034F
11.3.5.3.3. Y-o-Y Growth (%) 2024-2034F
11.3.5.4. Immunological Disorders
11.3.5.4.1. By Value (USD Million) 2024-2034F
11.3.5.4.2. Market Share (%) 2024-2034F
11.3.5.4.3. Y-o-Y Growth (%) 2024-2034F
11.3.5.5. Others
11.3.5.5.1. By Value (USD Million) 2024-2034F
11.3.5.5.2. Market Share (%) 2024-2034F
11.3.5.5.3. Y-o-Y Growth (%) 2024-2034F
12. North America Biomarkers Market Size & Forecast 2024A-2034F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Type
12.3.2. By Application
12.3.3. By Product Type
12.3.4. By Technology
12.3.5. By Indication
12.4. Country
12.4.1. United States
12.4.2. Canada
13. Europe Biomarkers Market Size & Forecast 2024A-2034F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Type
13.3.2. By Application
13.3.3. By Product Type
13.3.4. By Technology
13.3.5. By Indication
13.4. Country
13.4.1. Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14. Asia-Pacific Biomarkers Market Size & Forecast 2024A-2034F
14.1. Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Type
14.3.2. By Application
14.3.3. By Product Type
14.3.4. By Technology
14.3.5. By Indication
14.4. Country
14.4.1. India
14.4.2. China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15. Middle East and Africa Biomarkers Market Size & Forecast 2024A-2034F
15.1. Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Type
15.3.2. By Application
15.3.3. By Product Type
15.3.4. By Technology
15.3.5. By Indication
15.4. Country
15.4.1. Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4. South Africa
15.4.5. Rest of Middle East and Africa
16. Latin America Biomarkers Market Size & Forecast 2024A-2034F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Type
16.3.2. By Application
16.3.3. By Product Type
16.3.4. By Technology
16.3.5. By Indication
16.4. Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America
17. Competitive Landscape
17.1. Company market share, 2023
17.2. Key player overview
17.3. Key stakeholders
18. Company Profiles
18.1. Thermo Fisher Scientific Inc.
18.1.1. Company Overview
18.1.2. Financial Overview
18.1.3. Key Product; Analysis
18.1.4. Company Assessment
18.1.4.1. Product Portfolio
18.1.4.2. Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2. Roche Diagnostics
18.3. Abbott Laboratories
18.4. Siemens Healthineers
18.5. Danaher Corporation
18.6. Bio-Rad Laboratories, Inc.
18.7. GE Healthcare
18.8. Agilent Technologies, Inc.
18.9. Illumina, Inc.
18.10. Qiagen N. V.
18.11. Merck KGaA
18.12. PerkinElmer, Inc.
18.13. Bruker Corporation
18.14. BD (Becton, Dickinson and Company)
18.15. Hologic, Inc.
18.16. Other Prominent Players
19. Appendix
20. Consultant Recommendation
